0 Comentários
0 Compartilhamentos
849 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
AI in Neurology Market Outlook: Emerging Applications of AI in Brain HealthPolaris Market Research presents its latest market research report, titled AI in Neurology Market. It is a comprehensive market research report analyzing the fast-evolving AI in neurology market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics, and future scope for growth. The study is a combination of qualitative and...0 Comentários 0 Compartilhamentos 734 Visualizações 0 Anterior
-
AI in Neurology Market: Exploring Machine Learning Applications in Neurological ResearchThe AI in neurology market is gaining momentum as healthcare providers apply artificial intelligence to analyze neurological data, support clinical decisions, and improve the diagnosis of conditions such as Alzheimer's disease, Parkinson's disease, and stroke. Valued at USD 759.2 million in 2025, the market is projected to reach USD 945.6 million in 2026 and USD 5,619.9 million by 2034, growing...0 Comentários 0 Compartilhamentos 174 Visualizações 0 Anterior
-
Europe Neurology Clinical Trials Market: Advances in Precision NeurologyPolaris Market Research has published insightful research on Europe Neurology Clinical Trials Market. The research report offers an in-depth analysis of the market, covering all the major aspects, including market size, market share, growth drivers, and key trends. Besides, a thorough assessment of the annual forecast, strategies, and potential roadmaps has been provided in the study. The data...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Gabapentin Market Growth Strategies and Innovations in Neurology Treatment SolutionsThe prescription drug market continues to expand as healthcare systems prioritize effective treatments for chronic diseases, neurological disorders, and long-term pain management. At the same time, advancements in analgesic therapeutics and the growing neurology drugs market are reshaping pharmaceutical innovation, with increasing emphasis on non-opioid medications and generic drug...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Japan Neurology Clinical Trials Market: AI Trends Transforming Neurology Clinical TrialsWhy the Japan Neurology Clinical Trials Market Is Set to Nearly Double by 2034 — and What It Means for Pharma Leaders Targeting Japan Japan's aging population is driving one of the most closely watched neurology research pipelines in Asia, as domestic and global drugmakers race to bring new Alzheimer's and Parkinson's therapies through the country's fast-track regulatory system. According...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Neurology Clinical Trials Market: Key Trends Transforming Neurodegenerative Disease StudiesWhy the Neurology Clinical Trials Market Is Set to Nearly Double by 2034 — and What It Means for Pharma and CRO Leaders Alzheimer's, Parkinson's, and stroke are affecting a growing share of an aging global population, and the search for effective treatments is intensifying at a pace few other therapeutic areas can match. According to Polaris Market Research, the global Neurology Clinical...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
U.S. Neurology Clinical Trials Market: Advances in Precision Neurology and Personalized TherapiesWhy the U.S. Neurology Clinical Trials Market Is Set to Nearly Double by 2034 — and What It Means for Pharma and CRO Leaders With roughly 7 million Americans living with Alzheimer's disease alone, the pressure to bring new neurological therapies to market has rarely been higher — and the U.S. research infrastructure built to support that effort keeps expanding. According to Polaris...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
U.S. Neurology Clinical Trials Market: Advancing Approaches to Novel Neurological TherapiesThe U.S. Neurology Clinical Trials Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, U.S. Neurology Clinical Trials Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Africa Transcranial Stimulation Devices Market Growing at 5.5% CAGR Through 2033 as Mental Health Care ExpandsTranscranial stimulation devices are innovative, non-invasive medical technologies that modulate brain activity by delivering controlled magnetic or electrical stimulation to specific regions of the brain. They are widely used in the treatment of neurological and psychiatric disorders, including major depression, chronic pain, Parkinson's disease, stroke-related disabilities, traumatic brain...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Africa Transcranial Stimulation Devices Market to Grow at 5.5% CAGR by 2033Transcranial stimulation devices are advanced, non-invasive medical technologies used to modulate brain activity by delivering controlled magnetic or electrical stimulation to targeted regions of the brain. These devices provide an alternative to invasive neuromodulation procedures and are increasingly used across neurological, psychiatric, rehabilitation, cognitive, and pain-management...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
ASEAN Vagus Nerve Stimulation Devices Market Expected to Grow at a 9.9% CAGR Through 2033Vagus nerve stimulation (VNS) devices are advanced neurostimulation technologies that deliver mild electrical impulses to the vagus nerve to modulate neural activity and improve the functioning of the nervous system. By influencing communication between the brain and various organs, these devices help manage chronic neurological and psychiatric disorders that may not respond adequately to...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
ASEAN Vagus Nerve Stimulation Devices Market Set for 9.9% CAGR Growth by 2033Vagus nerve stimulation (VNS) devices are medical devices designed to deliver controlled electrical impulses to the vagus nerve, a major nerve connecting the brain with various organs in the body. These devices are used as a neuromodulation therapy to influence neural activity and support the management of certain neurological and functional disorders. VNS devices are generally...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
ASEAN Vagus Nerve Stimulation Devices Market to Grow at 9.9% CAGR Through 2033Vagus nerve stimulation (VNS) devices are medical devices designed to deliver controlled electrical impulses to the vagus nerve, a major nerve connecting the brain with various organs in the body. These devices are used as a neuromodulation therapy to influence neural activity and support the management of certain neurological and functional disorders. VNS devices are generally...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Benelux Deep Brain Stimulation Devices Market to Grow at 8.1% CAGR Through 2033Deep brain stimulation (DBS) devices are sophisticated implantable medical systems that use controlled electrical stimulation to modulate specific areas of the brain involved in neurological function. By delivering precise electrical impulses through implanted electrodes, these devices help reduce abnormal brain activity associated with movement disorders and certain neurological and...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Benelux Deep Brain Stimulation Devices Market to Reach US$ 38.0 Million by 2033Deep Brain Stimulation (DBS) devices are implantable neurostimulation systems that use carefully controlled electrical impulses to stimulate targeted areas of the brain. This therapy helps regulate abnormal brain signals associated with movement disorders and certain neurological or psychiatric conditions, providing symptom relief for patients who do not respond adequately to medication. DBS is...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
GCC Non-Invasive Neurostimulation Devices Market: 7.1% CAGR Through 2033Non-invasive neurostimulation devices are advanced medical technologies designed to stimulate targeted areas of the brain or nervous system without requiring surgical implantation. These devices use external magnetic fields, electrical currents, or ultrasound waves to influence neural activity and support therapeutic outcomes. Key technologies include transcranial magnetic stimulation...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
Páginas impulsionada
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek
